Introduction

▼
Follicular variant of papillary carcinoma (FVPTC) is the second most common variant of papillary thyroid cancer (PTC) and constitutes 9-22.5 % of all PTCs and it is a clinically distinct entity [1, 2] . Histologically, FVPTCs are similar to PTC in that they show clear nuclei, nuclear grooves and pseudoinclusions like PTC, but they have follicular cell architecture [3] . Unlike papillary carcinoma of the thyroid, FVPTC has a relatively benign ultrasound appearance and is often missed by radiologists [1, [3] [4] [5] [6] [7] . FVPTCs were previously described as hypoechoic or isoechoic, oval, well-defined lesions with halo and no microcalcifications [1, 7] . In our practice, we have often noticed certain other ultrasound findings not described so far in nodules which turned out to be FVPTC. However, we do not know how commonly these are seen and whether they can be in 44.1 % of FVPTC and 17 % of BTN. Younger patients, heterogeneous echotexture, nodule in nodule sign, thick incomplete non-uniform halo and presence of significant nodes were the best predictors of FVPTC (p < 0.05). The sensitivity, specificity, positive predictive value, negative predictive value, accuracy and relative risk for FVPTC given as odds ratio (95 % CI) for heterogeneous echotexture and nodule in nodule sign which were the best 2 predictors of FVPTC were 91.2 %, 81.8 %, 67.3 %, 95.7 %, 84.5 %, 46.5 (18.5-117.4) and 80.9 %, 87.7 %, 74.3 %, 91.2 %, 86.2 %, 32.5 (15.04-70.2), respectively. There was improvement in the specificity (91.5 %) and accuracy (86.6 %) when a combined criterion of heterogeneous echotexture and nodule in nodule sign was applied to predict FVPTC. Conclusion: The "nodule in nodule" sign is common in FVPTC and when combined with heterogeneous echotexture can differentiate FVPTC and BTN with high specificity.
License terms sis of FVPTC or benign thyroid nodule between Jan 2011 and Jan 2013. A total of 60 patients received a diagnosis of FVPTC and a total of 338 patients received a histopathological diagnosis of BTN during the study period. Patients were included in the study only if they underwent preoperative ultrasound of thyroid gland in our institution. All 60 patients (with 68 nodules in 13 males and 47 females with mean age of 39.5 ± 11.9 years) who received a diagnosis of FVPTC and only alternative consecutive patients who received a diagnosis of BTN which was a total of 150 patients (with 165 nodules in 41 males and 109 females with mean age of 44 ± 11.3 years) with BTN were included in the study. Among patients with FVPTC, the majority (81.7 %) had encapsulated variety of FVPTC (49 patients with 54 nodules) and the rest (11 patients with 14 nodules) had a diffuse or invasive form of FVPTC. 5 patients with encapsulated FVPTC had capsular breach, 1 patient had lymphovascular invasion and 7 had metastatic neck nodes. Among the patients with a diffuse form of FVPTC, 6 patients had capsular breach, 2 patients had lymphovascular invasion, 1 had extrathyroidal extension and 5 had metastatic neck nodes on histopathology. 2 patients with the diffuse form of FVPTC had bone metastases at presentation. The histopathological diagnosis of various BTNs was: 97 (58.8 %) cases of nodular hyperplasia; 19 (11.5 %) hurthle cell adenomas, 3 (1.8 %) cases of Hashimoto's thyroiditis; 23 (13.9 %) follicular adenomas and 23 (13.9 %) cases of adenomatous hyperplasia. Ultrasound of the thyroid was performed with a 7-12 MHz highfrequency ultrasound probe.
• ▶ Table 1 gives the list of ultrasound machines that were used at our institution to perform thyroid ultrasound. Ultrasound images of these patients were reviewed from picture archiving and communication system (PACS) by a single consultant radiologist with 7 years of radiology experience. The radiologist was blind to the final diagnosis. Ultrasound findings of each nodule were described and documented. The ultrasound features that were assessed were: nodule composition (solid, cystic, mixed), echogenicity (hyperechoic, isoechoic, hypoechoic, markedly hypoechoic), echotexture (homogeneous, heterogeneous), margins (well-defined with or without halo sign, microlobulated, ill-defined, irregular), presence of calcification (microcalcification, macrocalcification) and shape of the nodule (taller than wide or wider than tall). Nodules with > 75 % solid component were labeled as solid. Cystic nodules had no solid components, and mixed nodules had both solid and cystic areas with solid component constitution < 75 % of the size of the lesion. For mixed lesions echogenicity, margin, shape and presence of calcification were assessed for the solid component. Irrespective of the nodule composition, the presence of cystic change in the nodules was separately documented. Echogenicity was described in comparison with the thyroid gland and strap muscles. A lesion was considered hyperechoic if the echogenicity was more than that of the thyroid gland; isoechoic if the echogenicity was equal to thyroid gland; hypoechoic if the echogenicity was equal to strap muscle and markedly hypoechoic if the echogenicity was lower than the strap muscle. The echotexture was documented as homogeneous if the nodule had uniform echogenicity and heterogeneous if the echogenicity was variable ( • ▶ Fig. 1) . A hypoechoic smooth thin rim around the nodule was considered a positive halo sign. A halo sign was documented in detail and described if the halo was continuous or disrupted, uniform or non-uniform, thin ( < 1 mm) or thick ( > / = 1 mm) in nature ( • ▶ Fig. 1 ). Short cycle undulations of > 3 along the margin were considered a microlobulated margin. A spiculated margin was considered irregular while fuzzy margins were considered ill-defined. A calcification measuring less than 1 mm was defined as a microcalcification and a calcification of more than 1mm was labeled as a macrocalcification. The shape was described as taller than wide if the anterio-posterior dimension was equal to or greater than the transverse dimension and a nodule was described as wider than tall if the transverse dimension of the nodule was greater than the anterio-posterior dimension. Color Doppler findings were documented were available. Nodules were then assessed for 2 novel signs -the "nodule in nodule" sign and the "hypoechoic internal septae" sign. The 
Statistical analysis
IBM SPSS Analytics 16.0 software (Chicago, Ill., USA) was used for statistical analysis. Continuous variables were assessed using the Wisconsin rank sum test and categorical variables were assessed using the Chi square test. Binary logistic regression analysis was performed to identify the best ultrasound features which differentiate FVPTC from benign thyroid nodules and their diagnostic performance was assessed using ROC curve analysis.
Results
▼
• ▶ Table 2 summarizes the clinical and imaging features of FVPTC and BTN. The mean age of the patients with FVPTC (39.5 years) was significantly younger compared to BTN (44 years), p < 0.001. However, there was no difference in the sex distribution and the size of the nodules. 52 patients with FVPTC and 136 patients with BTN underwent FNAC. Our positive hit rate for FNAC was 65.4 % and 79.4 % for FVPTC and BTN, respectively. Among patients with FVPTC, 7.7 % (n = 4) had malignant cytology, 5.8 % (n = 3) had cytology which was suspicious for malignancy, 26.1 % (n = 14) had atypia of undetermined significance or follicular lesions and 25 % (n = 13) had benign cytology. Among the patients with BTN, 50 % (n = 68) had benign cytology, 28.6 % (n = 39) had atypia of undetermined significance or follicular lesions, only 1 patient (0.7 %) had cytology suspicious for malignancy and none had malignant cytology. A large majority of FVPTCs were solid (86.5 %), isoechoic (80.9 %), well-defined (69.1 %), oval in shape (61.8 %), showed peripheral vascularity (86.3 %) and had no calcifications (70.4 %). The major- • ▶ Table 3 shows the results of binary logistic regression analysis.
Of all the features, age, heterogeneous echotexture, positive nodule in nodule sign, thick non-uniform incomplete halo, and presence of significant nodes were the best predictors of FVPTC (p < 0.005). Echogenicity of the nodule, cystic change, hypoechoic internal septa sign, vascularity and calcification were not useful.
• ▶ Table 4 shows the diagnostic performance of the significant predictors of FVPTC.
Discussion
▼ FVPTC constitutes the second most common variant of papillary carcinoma of thyroid (PTC) next only to the classic variant of PTC and was first described by Crile and Hazard in 1953 [8] . Since then, the diagnosis of FVPTC has always been a diagnostic challenge for clinicians, pathologists and radiologists [9] . Clinically, FVPTC presents mostly as solitary nodules incidentally detected in patients around 40 years of age with male to female ratio of 1:6. Lymph node metastases precede lung metastases in FVPTC and the risk of regional nodal metastases is lower than PTC. Compared to patients with conventional PTC, patients with FVPTC have a better tumor risk group profile. However, the overall long-term survival among both types of PTC is similar [10, 11] . Diagnosis of FVPTC is not possible on FNAC and always needs surgical excision for definitive diagnosis [12] . In our series, very few patients with FVPTC had malignant cytology or cytology suspicious for malignancy. Nearly half of patients with FVPTC had either benign cytology or indeterminate cytology with atypical cells. FVPTCs have a unique histological appearance where the cells have a follicular architecture but the nuclei features are that of PTC. Although pathologists agree widely on the diagnostic criteria for FVPTC, concordance even among experienced pathologists is known to be variable and as low as 40 % [13] . Difficulty in differentiating between follicular adenomas and follicular carcinomas which are a close pathological differential diagnosis for FVPTC is the probable cause for the low concordance among pathologists [4] . FVPTCs are more commonly well encapsulated tumors with or without capsular invasion and less commonly they are diffusely infiltrative, as also seen in our series. Often, a histopathological diagnosis of FVPTC comes as a surprise to the sinologist. The majority (76 %) of encapsulated variety of FVPTC had no malignant features on ultrasound and were reported as benign in our series. On the other hand, 79 % of nodules which received histopathology diagnosis of invasive variety of FVPTC had one or more malignant features on ultrasound. FVPTCs have been described as well-defined, oval, isoechoic or hypoechoic nodules on ultrasound and less than 50 % showed one or more malignant ultrasound features [1, 4] . In our practice we have often noted a few previously undescribed ultrasound findings, i. e., the "nodule in nodule" sign and "hypoechoic internal septae" sign, in thyroid nodules which turned out to be FVPTC. This study was done to see the usefulness of these signs in differentiating FVPTC from BTN. We also went on to identify the best ultrasound predictors of FVPTC. The first sign -the "nodule in nodule" sign -represents discrete, hypoechoic or markedly hypoechoic areas within an isoechoic, well-defined thyroid nodule. This sign was very commonly (80 %) seen in FVPTC and was uncommon in BTN (12 %). A similar nodule in nodule appearance was also seen in the cut section of a thyroidectomy specimen of histopathologically proven FVPTC of thyroid ( • ▶ Fig. 4) . We know that highly cellular tumors, both benign and malignant, appear hypoechoic on ultrasound. Histopathologically, FVPTC has PTC like cells arranged in follicles and these follicles have variable amounts of colloid in the center of the follicles. We think that the histopathological reason for the nodule in nodule sign is tightly packed follicles with absent central colloid making that region more cellular compared to other areas with colloid in the follicles ( • ▶ Fig. 4) . However, we need focused radio-pathological correlation studies to prove this. Another possible pathological reason for this sign may be FVPTC arising within a BTN. However, only 5 FVPTCs were within benign thyroid nodules in our series and thus may not explain the commonality of this sign. The second sign -the "hypoechoic internal septae" sign -represents an ill-defined, hypoechoic branching septae like echoes within a well-defined isoechoic nodule. This sign was seen in 44 % of FVPTCs and 17 % of BTNs and its diagnostic performance was just fair (AUC = 0.648). The probable reason for this sign may be tumor, both FVPTC and BTN occurring in the background of diffuse thyroid disease which has fibrous septations within the gland. Studying for associated changes of diffuse thyroid disease, however, was beyond the scope of this study.
Of all the features we studied, regression analysis showed that the presence of heterogeneous echotexture, nodule in nodule sign, thick non-uniform incomplete halo and significant nodes were the best ultrasound predictors of FVPTC (p < 0.005). Other findings like the presence of cystic change, calcification, and hypoechoic internal septae were not useful. Heterogeneous echotexture was very commonly (91 %) seen in FVPTC and less commonly (18 %) in BTN. Heterogeneity, either heterogeneous echotexture or heterogeneous contrast enhancement in CT or MRI has been noted as a useful sign to differentiate malignant from benign lesions. For example, this is most useful in differentiating fibrolamellar hepatocellular carcinoma from focal nodular hyperplasia. Similarly, we found heterogeneous echotexture more commonly in FVPTC. The heterogeneous echotexture is probably due to the non-uniform arrangement of follicles, non-uniform size of the nucleus and heterogeneous cell [14] [15] [16] . However, their study included nodules with a wide range of histology including FVPTC. Although the halo sign was seen in 75 % of FVPTCs and more than 90 % of BTNs, the morphology of the halo sign was different between the 2. Nearly 80 % of FVPTCs had a thick, non-uniform halo while the halo was uniform in 85 % of BTNs. The non-uniform nature of the halo sign seen in FVPTC could be related to the presence of microscopic capsular invasion. The presence of metastatic neck nodes is a definite sign of malignancy, however was seen in only 18 % of patients with FVPTC. The diagnostic performance of heterogeneous echotexture was excellent (AUC of 0.902) followed by the nodule in nodule sign whose performance was good (AUC of 0.795). While the sensitivity of heterogeneous echotexture (91 %) was higher than the nodule in nodule sign (81 %), the specificity for the nodule in nodule sign (88 %) was higher than heterogeneous echotexture (82 %). There was marginal improvement of diagnostic accuracy (86.6 %) and excellent diagnostic performance (AUC = 0.833) when the combined criterion of heterogeneous echotexture and nodule in nodule sign was applied. However, adding the halo sign to the above combined criterion did not improve diagnostic accuracy (86.2 %) or performance. There are few limitations in this study. The retrospective nature of the study is a limitation. We had to go by images archived on PACS and ultrasound features may not have been adequately documented. Doppler findings were not documented in all patients and the value of color Doppler findings could not be fully brought out in this study. We did not match the nodules for size or patient characteristics and this is a limitation. The interand intra-observer variability among pathologists for the diagnosis of FVPTC even among experts is well known. This may have led to misclassification of a few patients.
In conclusion, heterogeneous echotexture, positive nodule in nodule sign, thick non-uniform incomplete halo and presence of significant lymph nodes were useful ultrasound findings to differentiate FVPTC and BTN. Heterogeneous echotexture and nodule in nodule sign or a combination of these 2 signs was the most useful in making an ultrasound diagnosis of FVPTC. The presence of these signs in a well-defined, benign appearing thyroid nodule should make thyroid sonologists consider FVPTC. This may prompt pathology colleagues to perform genetic tests to look for RAF/ BRAF mutations which will help them better characterize these lesions and may similarly prompt surgical colleagues to be more aggressive in the management of these nodules. Also, further prospective radio-pathological correlation studies are needed to validate the findings of this study.
